Details for New Drug Application (NDA): 010028
✉ Email this page to a colleague
NDA 010028 describes EQUANIL, which is a drug marketed by Wyeth Ayerst and is included in two NDAs. Additional details are available on the EQUANIL profile page.
The generic ingredient in EQUANIL is meprobamate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
The generic ingredient in EQUANIL is meprobamate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
Summary for 010028
| Tradename: | EQUANIL |
| Applicant: | Wyeth Ayerst |
| Ingredient: | meprobamate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 010028
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 005
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
